1. Home
  2. PLAB vs GHRS Comparison

PLAB vs GHRS Comparison

Compare PLAB & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$27.16

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$27.89

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
GHRS
Founded
1969
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PLAB
GHRS
Price
$27.16
$27.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$44.33
$41.38
AVG Volume (30 Days)
1.6M
148.5K
Earning Date
05-27-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
N/A
EPS
1.76
N/A
Revenue
$535,276,000.00
N/A
Revenue This Year
$6.70
N/A
Revenue Next Year
$4.96
N/A
P/E Ratio
$22.83
N/A
Revenue Growth
18.77
N/A
52 Week Low
$20.05
$12.04
52 Week High
$56.00
$31.44

Technical Indicators

Market Signals
Indicator
PLAB
GHRS
Relative Strength Index (RSI) 38.96 45.53
Support Level N/A $26.32
Resistance Level $34.71 $28.96
Average True Range (ATR) 1.57 0.95
MACD -0.06 -0.16
Stochastic Oscillator 3.69 37.13

Price Performance

Historical Comparison
PLAB
GHRS

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: